Samsung Biologics Co.,Ltd. (207940.KS) KSC
1,367,000.00
-10000(-0.73%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 78.38T |
| Enterprise Value | 79.16T |
| P/E Ratio | 33.66 |
| PEG Ratio | 0.72 |
| Price/Sales Ratio | 14.01 |
| Price/Book Ratio | 7.98 |
| Enterprise/Revenue | 14.16 |
| Enterprise/EBITDA | 26.2 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.42 |
| Operating Margin | 0.42 |
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 4.56T |
| Revenue/Share | 97,660.42 |
| Gross Profit | 2.48T |
| EBITDA | 2.7T |
| Net Income | 1.78T |
| Diluted EPS | 38,588 |
Balance Sheet
| Total Cash | 1.62T |
| Total Cash/Share | 35,042.45 |
| Total Debt | 1.19T |
| Total Debt/Equity | 0.15 |
| Current Ratio | 1.7 |
| Book Value Per Share | 171,341.6 |
Price History
| 52-Week Change | -13.76 |
| 52-Week High | 1.99M |
| 52-Week Low | 1.3M |
| Moving Average 50 Days | 1.5M |
| Moving Average 200 Days | 1.65M |
Statistics
| Average Volume | 55,845 |
| Shares Outstanding | 46.29M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 650391:1000000 |
| Last Split Date | October 30, 2025 |
